Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/GW501516> ?p ?o }
- GW501516 abstract "GW501516 (also known as GW-501,516, GW1516, GSK-516 and on the black market as Endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.In 2007 research was published showing that high doses of GW501516 given to mice dramatically improved their physical performance; the work was widely discussed in popular media, and led to a black market for the drug candidate and to its abuse by athletes as a doping agent. The World Anti-Doping Agency (WADA) developed a test for GW501516 and other related chemicals and added them to the prohibited list in 2009; it has issued additional warnings to athletes that GW501516 is not safe.".
- GW501516 atcPrefix "none".
- GW501516 casNumber "317318-70-0".
- GW501516 chEBI "73726".
- GW501516 iupacName "{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid".
- GW501516 pubchem "9803963".
- GW501516 thumbnail GW501,516.svg?width=300.
- GW501516 wikiPageID "16366361".
- GW501516 wikiPageLength "16191".
- GW501516 wikiPageOutDegree "57".
- GW501516 wikiPageRevisionID "681479754".
- GW501516 wikiPageWikiLink 2008_Beijing_Olympics.
- GW501516 wikiPageWikiLink 2008_Summer_Olympics.
- GW501516 wikiPageWikiLink Acadesine.
- GW501516 wikiPageWikiLink Agonist.
- GW501516 wikiPageWikiLink Animal_testing.
- GW501516 wikiPageWikiLink Benzodiazepine.
- GW501516 wikiPageWikiLink Benzodiazepines.
- GW501516 wikiPageWikiLink Black_market.
- GW501516 wikiPageWikiLink Bodybuilding.
- GW501516 wikiPageWikiLink Cardiovascular_disease.
- GW501516 wikiPageWikiLink Cardiovascular_diseases.
- GW501516 wikiPageWikiLink Category:Carcinogens.
- GW501516 wikiPageWikiLink Category:GlaxoSmithKline.
- GW501516 wikiPageWikiLink Category:PPAR_agonists.
- GW501516 wikiPageWikiLink Cell_(journal).
- GW501516 wikiPageWikiLink Coactivator_(genetics).
- GW501516 wikiPageWikiLink Combinatorial_chemistry.
- GW501516 wikiPageWikiLink Diabetes.
- GW501516 wikiPageWikiLink Diabetes_mellitus.
- GW501516 wikiPageWikiLink Diabetes_mellitus_type_2.
- GW501516 wikiPageWikiLink Drug_design.
- GW501516 wikiPageWikiLink Dyslipidemia.
- GW501516 wikiPageWikiLink Elena_Lashmanova.
- GW501516 wikiPageWikiLink Ergogenic.
- GW501516 wikiPageWikiLink Ergogenic_aid.
- GW501516 wikiPageWikiLink FNDC5.
- GW501516 wikiPageWikiLink GFT505.
- GW501516 wikiPageWikiLink GW0742.
- GW501516 wikiPageWikiLink Gene_doping.
- GW501516 wikiPageWikiLink GlaxoSmithKline.
- GW501516 wikiPageWikiLink High-density_lipoprotein.
- GW501516 wikiPageWikiLink Hyperlipidemia.
- GW501516 wikiPageWikiLink International_Olympic_Committee.
- GW501516 wikiPageWikiLink Irisin.
- GW501516 wikiPageWikiLink Leo_Sternbach.
- GW501516 wikiPageWikiLink Ligand_Pharmaceuticals.
- GW501516 wikiPageWikiLink Metabolic_syndrome.
- GW501516 wikiPageWikiLink Miguel_Ubeto.
- GW501516 wikiPageWikiLink New_Scientist.
- GW501516 wikiPageWikiLink Obesity.
- GW501516 wikiPageWikiLink PNAS.
- GW501516 wikiPageWikiLink PPARGC1A.
- GW501516 wikiPageWikiLink Performance-enhancing_drug.
- GW501516 wikiPageWikiLink Performance-enhancing_drugs.
- GW501516 wikiPageWikiLink Peroxisome_proliferator-activated_receptor.
- GW501516 wikiPageWikiLink Peroxisome_proliferator-activated_receptor_delta.
- GW501516 wikiPageWikiLink Phase_I_trials.
- GW501516 wikiPageWikiLink Phases_of_clinical_research.
- GW501516 wikiPageWikiLink Proceedings_of_the_National_Academy_of_Sciences_of_the_United_States_of_America.
- GW501516 wikiPageWikiLink Receptor_agonist.
- GW501516 wikiPageWikiLink Ronald_M._Evans.
- GW501516 wikiPageWikiLink RusVelo.
- GW501516 wikiPageWikiLink SR9009.
- GW501516 wikiPageWikiLink Sodelglitazar.
- GW501516 wikiPageWikiLink Structure-based_drug_design.
- GW501516 wikiPageWikiLink Type_II_diabetes.
- GW501516 wikiPageWikiLink Valery_Kaykov.
- GW501516 wikiPageWikiLink Very-low-density_lipoprotein.
- GW501516 wikiPageWikiLink Very_low-density_lipoprotein.
- GW501516 wikiPageWikiLink Vuelta_Ciclista_a_Costa_Rica.
- GW501516 wikiPageWikiLink World_Anti-Doping_Agency.
- GW501516 wikiPageWikiLinkText "GW501516".
- GW501516 atcPrefix "none".
- GW501516 c "21".
- GW501516 casNumber "317318".
- GW501516 chebi "73726".
- GW501516 chembl "38943".
- GW501516 chemspiderid "7979723".
- GW501516 f "3".
- GW501516 h "18".
- GW501516 hasPhotoCollection GW501516.
- GW501516 iupacName "{4-[sulfanyl]-2-methylphenoxy}acetic acid".
- GW501516 iupharLigand "2687".
- GW501516 legalAu "unscheduled".
- GW501516 legalUk "unscheduled".
- GW501516 legalUs "unscheduled".
- GW501516 molecularWeight "453.498".
- GW501516 n "1".
- GW501516 o "3".
- GW501516 pregnancyCategory "N/A".
- GW501516 pubchem "9803963".
- GW501516 routesOfAdministration "oral".
- GW501516 s "2".
- GW501516 smiles "O=CO".
- GW501516 stdinchi "1".
- GW501516 stdinchikey "YDBLKRPLXZNVNB-UHFFFAOYSA-N".
- GW501516 tradename "Endurobol".
- GW501516 verifiedfields "changed".
- GW501516 verifiedrevid "458657924".